WRAL Tech Wire

 LabCorp's earnings, revenue fall shy of analyst estimates

LabCorp said that margins were negatively affected by weather, Medicare payment reductions and the number of days in the quarter.

 LabCorp lands five-year biomarker test deal with Squibb

The lab testing giant signs a contract for services and biomarker testing with Bristol-Myers Squibb. LabCorp also says it is expanding tests related to inflammatory bowel disease.

 LabCorp launching $1B share buyback program

LabCorp, the lab testing giant, said Friday it is launching a $1 billion share buyback program.

 Former LabCorp CEO, chairman to retire from board

Thomas Mac Mahon, chief executive officer at LabCorp for a decade who then became the firm;s chairman, is retiring from the board of directors.

 LabCorp plans to sell $1 billion in bonds

The lab testing firm, which earlier this month was the subject of leveraged buyout rumors on Wall Street, is selling bonds in two $500 million packages.

 LabCorp denies any knowledge of a possible buyout

The lab testing firm, which is based in Burlington, says it is "aware" of possible buyout talk but says it's "not in current discussions."

 Revenues, earnings increase for LabCorp in Q2

 LabCorp nears $2B in deals as acquisition binge continues

The Burlington-based company's latest deal - $241 million for Medtox Scientific - is just the latest in a series of acquisitions made over the past three years.

Timeline tracks LabCorp's history, growth

 LabCorp to acquire testing services firm in $241M deal

Burlington-based Laboratory Corporation of America agrees to buy Medtox Scientific in an all-cash deal worth $241 million.

 LabCorp to develop new lupus inflammation

Burlington-based LabCorp will work with XDx to develop a biomarker and commercialize a test for the flares -- extended periods of activity for the autoimmune disease. Lupus causes the body's immune system to attack its own tissues, which leads to inflammation and organ damage.

 LabCorp licenses new Alzheimer's disease diagnostic

Alzheimer's disease affects more than five million people in the United States and more than 35 million worldwide. There are no specific tests available to detect Alzheimer's disease and track its progression. Diagnosis is currently conducted by behavioral and cognitive measurements.

 Tech news: Alien Skin, SciQuest, DataFlux, LabCorp, Verizon Wireless

Alien Skin's latest software; SciQuest lands new customer; DadaFlux launches "Learning Café;" LabCorp revenue climbs; Verizon's 4G plans in NC.

 $1B credit facility for LabCorp

LabCorp said it has set $1 billion in credit in an arrangement with Bank of America.

 LabCorp finally closes on $85M acquisition of DNA testing firm

Laboratory testing and diagnostics firm LabCorp has secured the greater than 90 percent of shares in Orchid that allowed the company to proceed with a short-form merger, meaning the deal could go through without a shareholders meeting.

 FTC approves LabCorp's $85.4M deal for DNA testing firm

However, as part of the deal LabCorp must sell paternity testing business done for U.S. government to another firm.

 Will personalized medicine deliver on its promises?

There is no shortage of companies angling for financial backing of new therapies and diagnostics in personalized medicine. But will challenges of regulations, reimbursements, costs and technical requirements be overcome?

 Newsmakers: SciQuest, ChannelAdvisor, LabCorp, Bayer CropScience, Red Hat

SciQuest wins Texas hospital business; ChannelAdvisor adds 26 auto dealers; LabCorp extends Orchid Cellmark offer; Bayer CropScience names new exec; Red Hat Summit seeks papers.

 LabCorp faces Medicare, Medicaid billing probe

Senators ask the company to provide information about discounted or below cost lab services offered to managed care organizations and payers in exchange for referrals of other laboratory testing business to LabCorp.

 LabCorp extends again its offer for shares in Orchid Cellmark

 Making headlines: LabCorp, SciQuest, Synexcis, Precision

LabCorp extends stock offer; Synexcis signs reseller; SciQuest joins two trade groups; Precision BioSciences files patent suit.